Blood components: current challenges.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine

PubMedID: 18420438

Rouger P. Blood components: current challenges. Transfus Clin Biol. 2007;14(6):496-8.
Labile blood products are still here to stay for quite a long time. All European surveys come in agreement to reveal that indications, extremely heterogeneous from one country to another, are not fully under control. Both the EuroNet-TMS network and Euro'SAT congresses aim at improving the use of such products within an evidence-based medicine perspective.